NCT05933590Completed
Cervical Repositioning Error in Chronic Migraine
Cervical Joint Repositioning Error in Different Head Positions Among Individuals With Chronic Migraine: A Cross-Sectional Study
Source: ClinicalTrials.gov · Last updated 22 Jan 2024
Brief summary (registry, in English)
This study examines cervical joint position sense in individuals with chronic migraine vs. healthy controls. The ability to reposition the cervical spine after active movement will be evaluated in different head positions. Impaired proprioception and motor control is hypothesized in the migraine group.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 50 (actual)
- First submitted
- 28 Jun 2023
- Start date
- 1 Jul 2023
- Primary completion date
- 6 Jan 2024
- Lead sponsor
- Ahram Canadian University
- Diseases
- Migraine
- NCT number
- NCT05933590
What you commit to
- Study type: Observational
- Participants enrolled: 50
- From 1 Jul 2023 to the primary completion date, 6 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of cervical spine pathology
Other
- Neurological deficits unrelated to migraine
- Current pregnancy
Who the study is looking for
- Individuals aged 18-65 years old
- Diagnosis of chronic migraine (for the chronic migraine group)
- No history of migraine (for the control group)
Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Outpatient clinic of faculty of physical therapy, Ahram Canadian University Coordinator of this site? Confirm its status | Al Ḩayy Ath Thāmin | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.